Exobiosphere
PrivateLast Round
VC Round
Apr 1, 2026
Total Funding Raised
$3.61M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Exobiosphere is a biotechnology company that develops automated, space-based high-throughput screening platforms to accelerate drug discovery and preclinical research in microgravity.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Space Technology, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exobiosphere Comparables
Compare Exobiosphere with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpacePharma | 84% | |
| Helogen Corporation | 83% | |
| Space LiinTech | 83% |
Exobiosphere Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2026 | ||||
| Seed | Nov 3, 2025 | ||||
| Seed | Apr 4, 2025 |
Exobiosphere Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Expon Capital | Seed |
| Expansion Ventures | Seed |
| Cedars-Sinai Intellectual Property Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2026
Grew 38% QoQ, from 21 to 29 employees.
- Jul 25, 2026
Monthly visitors increased 55% MoM.
Recent news
Latest coverage and updates
- launchesSep 24, 2026
Exobiosphere schedules installation of its Orbital High-Throughput Screening in Microgravity (OHTS) platform aboard the ISS in Apr '27
- receives_financingAug 12, 2026
Exobiosphere received financing of $1.15M in non-dilutive financing on Aug 12th '26.
- receives_financingAug 11, 2026
Exobiosphere received financing of $1.16M in non-dilutive funding on Aug 11th '26.
Exobiosphere Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exobiosphere's valuation, stock price, and market status.
Is Exobiosphere a public or private company?
Exobiosphere is a private company.
What is the current stock price of Exobiosphere?
Exobiosphere is a private company, so its shares have no public market price. Caplight tracks Exobiosphere's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exobiosphere worth (valuation)?
Valuation information for Exobiosphere is not publicly available.
Can I buy Exobiosphere stock?
Exobiosphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exobiosphere's last funding round?
Exobiosphere's most recent funding round was VC Round on April 1, 2026.
Who are the main investors in Exobiosphere?
Key investors in Exobiosphere include Expansion Ventures, Cedars-Sinai Intellectual Property Company.
Will Exobiosphere IPO soon?
No public IPO plans have been announced for Exobiosphere.
How can I track Exobiosphere secondary market activity?
Caplight tracks bids, offers, and trades in Exobiosphere's shares on secondary markets.